Insider Transactions in Q3 2024 at Candel Therapeutics, Inc. (CADL)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 17
2024
|
Paul Peter Tak Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,528
-6.38%
|
$135,168
$6.47 P/Share
|
|
Jul 17
2024
|
Seshu Tyagarajan Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
14,851
-9.23%
|
$89,106
$6.47 P/Share
|
|
Jul 17
2024
|
Francesca Barone Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
14,051
-8.07%
|
$84,306
$6.47 P/Share
|
|
Jul 17
2024
|
William Garrett Nichols Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,875
-8.68%
|
$65,250
$6.47 P/Share
|
|
Jul 17
2024
|
Charles Schoch |
SELL
Open market or private sale
|
Direct |
9,884
-13.65%
|
$59,304
$6.47 P/Share
|
|
Jul 11
2024
|
Paul Peter Tak Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,293
-5.43%
|
$101,465
$5.97 P/Share
|
|
Jul 11
2024
|
Seshu Tyagarajan Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
13,330
-7.65%
|
$66,650
$5.97 P/Share
|
|
Jul 11
2024
|
Francesca Barone Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,645
-6.77%
|
$63,225
$5.97 P/Share
|
|
Jul 11
2024
|
William Garrett Nichols Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,769
-7.23%
|
$48,845
$5.97 P/Share
|
|
Jul 11
2024
|
Charles Schoch |
SELL
Open market or private sale
|
Direct |
8,897
-10.94%
|
$44,485
$5.97 P/Share
|